Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

$10 Million Private Placement of Ainos, Inc.

Represented Maxim Group LLC, as lead placement agent, for the $10 Million private placement of Ainos, Inc. a healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine.

Loeb’s IP/patent team conducted patent and IP diligence on the target company, and drafted and negotiated IP provisions of the Registration Statement, opinions of IP counsel, investor presentation and transaction documents.